Your browser doesn't support javascript.
loading
Is Pakistan at the cusp of an ART resistance?
Altaf, Arshad.
Afiliação
  • Altaf A; WHO HIV, Hepatitis and STI Programmes, Switzerland.
J Pak Med Assoc ; 70(11): 2046-2047, 2020 Nov.
Article em En | MEDLINE | ID: mdl-33341857
ABSTRACT
Only 10% of HIV positive individuals in Pakistan are receiving anti-retroviral therapy (ART) and the dropout rate from HIV treatment is extremely high. This short report attempts to highlight the risk of ART resistance. Pakistan National AIDS Control Programme's website reports 15,390 HIV positive persons receiving ART out of which 4,697 (30.5%) are people who inject drugs (PWIDs) among whom HIV prevalence is reported to be 38.4%. In the two large provinces of the country (Punjab and Sindh) with more than 90% burden of HIV, ART was initiated in 2,807 patients between April and September 2018, out of these 37% were lost to follow up. Many patients have cited issues related to quality of service at the ART centres as one of the reasons to not revisiting the treatment centres. HIV planners in Pakistan urgently need to make a new strategy and improve not only the quality of services but also increase the number of HIV positive persons receiving ART.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Infecções por HIV Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Pak Med Assoc Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Infecções por HIV Tipo de estudo: Prevalence_studies / Risk_factors_studies Limite: Humans País/Região como assunto: Asia Idioma: En Revista: J Pak Med Assoc Ano de publicação: 2020 Tipo de documento: Article